Cellular immunotherapies have shown great promise in the treatment of various diseases. Chimeric engulfment receptor (CER)-engineered T cells were developed to utilize the extracellular T-cell immunoglobulin and mucin domain-containing 4 (TIM-4) domain and intracellular engulfment signaling domains to target and enhanc...
K. Eichholz, A. Okoye, B. Varco-Merth et al.· AIDS Research and Human Retr...· 0 citations
T4IL15Δ is engineered, a bispecific biologic that selectively delivers IL-15 signaling to memory CD4 T cells, with minimal off-target stimulation, and provides a robust reactivation platform that could complement other reservoir-elimination strategies toward an HIV-1 cure.
Yao-Xing Huang, M. Nair, J. Yu et al.· bioRxiv· 0 citations
Natural killer (NK) cells lead a rapid and potent innate immune response following exposure to infectious agents, but their activity may also contribute to chronic inflammation and augmented disease pathogenesis. Previous reports have shown that Janus kinase 3 inhibitors or anti-IL-15 monoclonal antibodies potently dep...
Taylor M. Oeschger, B. Varco-Merth, Carly E. Starke et al.· Human Gene Therapy· 0 citations
People living with HIV (PLWH) on suppressive antiretroviral therapy (ART) can face non-AIDS complications, partially driven by chronic immune activation. To define immune perturbations during ART-suppressed viral infection, we performed longitudinal single-cell transcriptomic and plasma proteomic analyses of rhesus mac...
Maanasa Kaza, B. Varco-Merth, G. McElfresh et al.· Cell Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.